Skip to main content
Marla Daves, MD

Marla Daves, MD

  • Affiliate Physician

Departments

Certifications

  • American Board of Preventative Medicine, Clinical Informatics 
  • American Board of Pediatrics, Pediatric Hematology/Oncology
  • American Board of Pediatrics, Pediatric

Education

  • MD, University of Alabama School of Medicine, 2003
  • MS, Health Informatics, University of Texas Health Science Center School of Bomedical Informatics, 2011
  • B.S., Mathematics, University of Alabama, 1999

Honors

  • NIH Pediatric Loan Repayment Recipient (2008-2010, 2011-2012)
  • American Medical Women's Association Award (2003)
  • Pathology Honors Society 2001 Alpha Omega Alpha (2002)
  • Board of Medical Merit Scholarships Award (2000-2003)
  • B. B. Comer Mathematics Medal (top graduate in Mathematics) (1999)

Professional Memberships

  • Health Information and Management Systems Society (2016 - Present)
  • Children’s Oncology Group (2009 - Present)
  • American Medical Informatics Association (2009 - Present)
  • American Society of Pediatric Hematology/Oncology  (2007 - Present)

Selected Publications

Wright TE, Shah MD, Rider NL, Porea TJ, Musick MA, Miller J, Daves M, Foster JH, Anvari S. A case-series of pediatric oncology patients undergoing successful rapid etoposide desensitization. Pediatr Allergy Immunol. Apr 9. 2019 . [Epub ahead of print]

Miller TP, Li Y, Kavcic M, Getz KD, Huang YV, Sung L, Alonzo TA, Gerbing R, Daves MH, Horton TM, Pulsipher MA, Pollard J, Bagatell R, Seif AE, Fisher BT, Luger S, Gamis AS, Adamson PC, Aplenc R. Center-level variation in accuracy of adverse event reporting in a clinical trial for pediatric acute myeloid leukemia: a report from the Children's Oncology Group. Haematologica. 2017 Sep;102(9):e340- e343. Epub Jun 22, 2017. PMID 28642300

Miller TP, Getz KD, Kavcic M, Li Y, Huang YS, Sung L, Alonzo TA, Gerbing R, Daves MH, Horton TM, Pulsipher M, Pollard J, Bagatell R, Seif AE, Fisher BT, Gamis A, Aplenc R. A comparison of discharge strategies after chemotherapy completion in pediatric patients with acute myeloid leukemia: A  report from the Children’s Oncology Group. Leukemia and Lymphoma,  4:1-8. 2016 PMID: 26727639.

Miller TP, Li Y, Kavcic M, Troxel AB, Huang YS, Sung L, Alonzo TA, Gerbing RB, Hall M, Daves MH, Horton TM, Pulsipher MA, Pollard J, Bagatell R, Seif AE, Fisher BT, Luger SM, Gamis AS, Adamson PC, Aplenc R. Accuracy of adverse event ascertainment on clinical trials for pediatric acute myeloid leukemia. Journal of Clinical Oncology, 2016 May 1;34(13):1537-43. 2016 PMID: 26884558

Nickel RS, Daves M, Keller F. Treatment of an adolescent with chronic myeloid leukemia and the T315I mutation with ponatinib. Pediatr Blood Cancer. 2015 May 4. doi: 10.1002/pbc.25551. Nickel RS, Keller F, Bergsagel J, Cooper T, Daves M, Sabnis H, Lew G. Mitoxantrone as a substitute for daunorubicin during induction in newly diagnosed lymphoblastic leukemia and lymphoma. Pediatr Blood Cancer. 2014 May;61(5):810-4.  Epub Dec 19, 2013 .

Hockenberry MJ, McCarthy KS, Taylor OA, Hesselgrave J, Bernhardt MB, Daves M, Kamdar K. Using improvement science to promote evidence-based practice in a childhood cancer and hematology center. J Pediatr Oncol Nurs. 2012 Jan; 29(1):5-13. 2012 (PMID: 22367765)

Daves MH, Hilsenbeck SG, Lau CC, Man TK. Meta-analysis of multiple microarray datasets reveals a common gene signature of metastasis in solid tumors. BMC Medical Genomics 4:56 (7 July 2011).  2011

Last update: November 2019

Close